NCT04102891

Brief Summary

FLORA is a longitudinal intervention study with a randomized, parallel group design. Primary objective is to improve metabolic health through gut microbiota modulation by means of a retailer-driven personalized dietary intervention in a real-life setting. Four hundred Flemish pre-metabolic adults will be randomly divided into a control and treatment arm, each comprising 200 participants. The study period is divided into three phases: a four weeks characterization, a twelve weeks intervention, and a four weeks post-intervention phase. During the intervention phase, control participants' online Collect\&Go shopping carts are adjusted in accordance with Flemish food-based dietary guidelines. Based on the same guidelines, participants are provided with personalized dietary advice considering their usual dietary pattern and level of food literacy. In the treatment arm, a similar intervention will be applied using guidelines based on a microbiota modulation diet (MMD). During intervention, all participants can contact a dietician helpline for additional advice on study-related dietary issues. Over the five months, saliva and fecal samples will be collected on a regular basis, with an intensive sampling period of seven consecutive days at the end of each study phase. A GP consult consisting of a short medical exam, blood withdrawal and medical questionnaire takes place each month. Further, online questionnaires on lifestyle, health and well-being will be sent by e-mail and each five days, participants complete a food diary through their smartphone. Fecal, saliva, blood samples and meta-data will be analysed to detect changes in metabolic health.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2021

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 18, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 25, 2019

Completed
1.4 years until next milestone

Study Start

First participant enrolled

February 1, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2021

Completed
Last Updated

October 22, 2020

Status Verified

September 1, 2020

Enrollment Period

4 months

First QC Date

September 18, 2019

Last Update Submit

October 19, 2020

Conditions

Keywords

Metabolic syndromeGut microbiotaPersonalized dietary adviceFood literacy

Outcome Measures

Primary Outcomes (5)

  • Reduced waist circumference

    Participants' waist circumference (cm) decreases during the study period

    5 months

  • Reduced serum triglycerides

    Participants' serum triglyceride level (mg/dL) decreases during the study period (blood sample analysis)

    5 months

  • Reduced blood pressure

    Participants' blood pressure (mm Hg) decreases during the study period

    5 months

  • Elevated HDL-cholesterol

    Participants' HDL-cholesterol levels (mg/dL) increase during the study period (blood sample analysis)

    5 months

  • Reduced fasting plasma glucose

    Participants' fasting plasma glucose levels decrease during the study period (blood sample analysis)

    5 months

Study Arms (2)

Study arm

EXPERIMENTAL

During the three months intervention period, participants within this arm will do their groceries through the online Collect\&Go platform of Colruyt Group. Dietitians will adjust their shopping carts by changing food products by healthier alternative ones taking into account the Flemish food-based dietary guidelines. Based on participants' dietary pattern and level of food literacy, personalized dietary advice will be provided and a dietitian helpline will be available for further nutrition-related questions.

Other: Microbiota modulation diet

Control arm

NO INTERVENTION

During the three months intervention period, participants within this arm will do their groceries through the online Collect\&Go platform of Colruyt Group. Dietitians will adjust their shopping carts by changing food products by healthier alternative ones taking into account the guidelines from the newly developed microbiota modulation diet (MMD). Based on participants' dietary pattern and level of food literacy, personalized dietary advice will be provided and a dietitian helpline will be available for further nutrition-related questions.

Interventions

The Collect\&Go shopping carts of the 400 participants will be adapted by replacing food products by healthier alternative ones based on the Flemish food-based dietary guidelines and the microbiota modulation diet guidelines for the control and study arm respectively. Based on these guidelines, and the habitual dietary pattern and level of food literacy of the participant, personalized dietary advice will be provided. A dietitian helpline will be available for further nutritional issues as well.

Study arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Willingness to participate to the study and to sign the informed consent (Dutch)
  • Older than 18 years
  • Diagnosed with pre-metabolic syndrome (diagnosed with central obesity \[waist circumference ≥80 cm for women and ≥94 cm for men\] and one of the following criteria: elevated blood pressure \[systolic ≥130 mm Hg, diastolic ≥85 mm Hg\], raised triglycerides \[\>150 mg/dL\], reduced HDL-cholesterol \[\<40 mg/dL in men, \<50 mg/dL in women\], or raised fasting plasma glucose \[≥100 mg/dL\]
  • Residing in Belgium, no travels abroad planned longer than seven consecutive days during the five-months study period
  • Willingness to follow dietary guidelines during the three-months intervention period
  • Willingness to purchase bulk groceries primarily at Colruyt Group using the Collect\&Go platform during the five-months study period
  • Access to a -20-18°C freezer

You may not qualify if:

  • Chronic constipation (less than one defecation once a week)
  • Gastro-intestinal surgery within the past 3 months
  • Inflammatory bowel disease (IBD) or diverticulitis
  • Irritable bowel syndrome (IBS)
  • Any food allergy or food intolerance
  • Metabolic syndrome
  • Diabetes Mellitus Type 1 or Type 2
  • Coeliac disease
  • Pregnant women or women planning a pregnancy during the study period
  • Lactating women
  • Subjects on a specific diet (e.g. vegetarian/vegan diet, gluten-free diet, lactose-free diet, high-protein diet)
  • Subjects being treated for hypertension or high cholesterol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Metabolic Syndrome

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2019

First Posted

September 25, 2019

Study Start

February 1, 2021

Primary Completion

June 1, 2021

Study Completion

July 1, 2021

Last Updated

October 22, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share